Calendar

Financial Releases

Date Title  
Toggle Summary AbbVie Increases Quarterly Dividend by 11 Percent
NORTH CHICAGO, Ill. , Oct. 27, 2017 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) increased the company's quarterly cash dividend by 11 percent from $0.64 per share to $0.71 per share.  The cash dividend is payable February 15, 2018 to shareholders of record at the close of
Toggle Summary AbbVie to Present at the 2017 Credit Suisse Health Care Conference
NORTH CHICAGO, Ill. , Oct. 18, 2017 /PRNewswire/ --  AbbVie (NYSE: ABBV) will participate in the 2017 Credit Suisse Health Care Conference on Wednesday, November 8, 2017 . Bill Chase , executive vice president and chief financial officer, will present at 12 p.m. Central time .
Toggle Summary AbbVie to Host Third-Quarter 2017 Earnings Conference Call
NORTH CHICAGO, Ill. , Oct. 9, 2017 /PRNewswire/ --  AbbVie (NYSE: ABBV) will announce its third-quarter 2017 financial results on Friday, Oct. 27, 2017 , before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time ( 9 am Eastern).
Toggle Summary AbbVie Declares Quarterly Dividend
NORTH CHICAGO, Ill. , Sept. 8, 2017 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) declared a quarterly cash dividend of $0.64 per share.  The cash dividend is payable Nov. 15, 2017 to stockholders of record at the close of business on Oct. 13, 2017 .
Toggle Summary AbbVie to Present at the Morgan Stanley 15th Annual Global Health Care Conference
NORTH CHICAGO, Ill. , Sept. 7, 2017 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Morgan Stanley 15 th Annual Global Health Care Conference on Tuesday, Sept. 12, 2017 . Richard A. Gonzalez , chairman and chief executive officer, will present at 10:10 a.m. Central time .
Toggle Summary AbbVie Reports Second-Quarter 2017 Financial Results
- Reports Second-Quarter Diluted EPS of $1.19 on a GAAP Basis; Adjusted Diluted EPS of $1.42, Reflecting Growth of 12.7 Percent - Delivers Second-Quarter Net Revenues of $6.944 Billion; Adjusted Net Revenues Increased 8.9 Percent on an Operational Basis - Second-Quarter Global Humira Sales of
Toggle Summary AbbVie to Host Second-Quarter 2017 Earnings Conference Call
NORTH CHICAGO, Ill. , July 10, 2017 /PRNewswire/ --  AbbVie (NYSE: ABBV) will announce its second-quarter 2017 financial results on Friday, July 28, 2017 , before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time ( 9 am Eastern).
Toggle Summary AbbVie Declares Quarterly Dividend
NORTH CHICAGO , Ill. , June 22, 2017 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) declared a quarterly cash dividend of $0.64 per share.  The cash dividend is payable Aug. 15, 2017 to stockholders of record at the close of business on July 14, 2017 .
Toggle Summary AbbVie to Present at the Goldman Sachs 38th Annual Global Healthcare Conference
NORTH CHICAGO, Ill. , May 24, 2017 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Goldman Sachs 38 th Annual Global Healthcare Conference on Tuesday, June 13, 2017 . Bill Chase , executive vice president and chief financial officer, will present at 10 a.m. Central time .
Toggle Summary AbbVie to Present at the Jefferies 2017 Global Healthcare Conference
NORTH CHICAGO, Ill. , May 19, 2017 /PRNewswire/ --  AbbVie (NYSE: ABBV) will participate in the Jefferies 2017 Global Healthcare Conference on Thursday, June 8, 2017 . Bill Chase , executive vice president and chief financial officer, will present at 1:30 p.m. Central time .